Cargando…
Combination therapy of an IL-15 superagonist complex, ALT-803, and a tumor targeting monoclonal antibody promotes direct antitumor activity and protective vaccinal effect in a syngenic mouse melanoma model
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649322/ http://dx.doi.org/10.1186/2051-1426-3-S2-P347 |
| _version_ | 1782401332896858112 |
|---|---|
| author | Chen, Xiaoyue Liu, Bai Han, Kaiping Kong, Lin Noel, Terra Jeng, Emily K Alter, Sarah Rubinstein, Mark Rhode, Peter R Wong, Hing C |
| author_facet | Chen, Xiaoyue Liu, Bai Han, Kaiping Kong, Lin Noel, Terra Jeng, Emily K Alter, Sarah Rubinstein, Mark Rhode, Peter R Wong, Hing C |
| author_sort | Chen, Xiaoyue |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4649322 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46493222015-11-24 Combination therapy of an IL-15 superagonist complex, ALT-803, and a tumor targeting monoclonal antibody promotes direct antitumor activity and protective vaccinal effect in a syngenic mouse melanoma model Chen, Xiaoyue Liu, Bai Han, Kaiping Kong, Lin Noel, Terra Jeng, Emily K Alter, Sarah Rubinstein, Mark Rhode, Peter R Wong, Hing C J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4649322/ http://dx.doi.org/10.1186/2051-1426-3-S2-P347 Text en Copyright © 2015 Chen et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Chen, Xiaoyue Liu, Bai Han, Kaiping Kong, Lin Noel, Terra Jeng, Emily K Alter, Sarah Rubinstein, Mark Rhode, Peter R Wong, Hing C Combination therapy of an IL-15 superagonist complex, ALT-803, and a tumor targeting monoclonal antibody promotes direct antitumor activity and protective vaccinal effect in a syngenic mouse melanoma model |
| title | Combination therapy of an IL-15 superagonist complex, ALT-803, and a tumor targeting monoclonal antibody promotes direct antitumor activity and protective vaccinal effect in a syngenic mouse melanoma model |
| title_full | Combination therapy of an IL-15 superagonist complex, ALT-803, and a tumor targeting monoclonal antibody promotes direct antitumor activity and protective vaccinal effect in a syngenic mouse melanoma model |
| title_fullStr | Combination therapy of an IL-15 superagonist complex, ALT-803, and a tumor targeting monoclonal antibody promotes direct antitumor activity and protective vaccinal effect in a syngenic mouse melanoma model |
| title_full_unstemmed | Combination therapy of an IL-15 superagonist complex, ALT-803, and a tumor targeting monoclonal antibody promotes direct antitumor activity and protective vaccinal effect in a syngenic mouse melanoma model |
| title_short | Combination therapy of an IL-15 superagonist complex, ALT-803, and a tumor targeting monoclonal antibody promotes direct antitumor activity and protective vaccinal effect in a syngenic mouse melanoma model |
| title_sort | combination therapy of an il-15 superagonist complex, alt-803, and a tumor targeting monoclonal antibody promotes direct antitumor activity and protective vaccinal effect in a syngenic mouse melanoma model |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649322/ http://dx.doi.org/10.1186/2051-1426-3-S2-P347 |
| work_keys_str_mv | AT chenxiaoyue combinationtherapyofanil15superagonistcomplexalt803andatumortargetingmonoclonalantibodypromotesdirectantitumoractivityandprotectivevaccinaleffectinasyngenicmousemelanomamodel AT liubai combinationtherapyofanil15superagonistcomplexalt803andatumortargetingmonoclonalantibodypromotesdirectantitumoractivityandprotectivevaccinaleffectinasyngenicmousemelanomamodel AT hankaiping combinationtherapyofanil15superagonistcomplexalt803andatumortargetingmonoclonalantibodypromotesdirectantitumoractivityandprotectivevaccinaleffectinasyngenicmousemelanomamodel AT konglin combinationtherapyofanil15superagonistcomplexalt803andatumortargetingmonoclonalantibodypromotesdirectantitumoractivityandprotectivevaccinaleffectinasyngenicmousemelanomamodel AT noelterra combinationtherapyofanil15superagonistcomplexalt803andatumortargetingmonoclonalantibodypromotesdirectantitumoractivityandprotectivevaccinaleffectinasyngenicmousemelanomamodel AT jengemilyk combinationtherapyofanil15superagonistcomplexalt803andatumortargetingmonoclonalantibodypromotesdirectantitumoractivityandprotectivevaccinaleffectinasyngenicmousemelanomamodel AT altersarah combinationtherapyofanil15superagonistcomplexalt803andatumortargetingmonoclonalantibodypromotesdirectantitumoractivityandprotectivevaccinaleffectinasyngenicmousemelanomamodel AT rubinsteinmark combinationtherapyofanil15superagonistcomplexalt803andatumortargetingmonoclonalantibodypromotesdirectantitumoractivityandprotectivevaccinaleffectinasyngenicmousemelanomamodel AT rhodepeterr combinationtherapyofanil15superagonistcomplexalt803andatumortargetingmonoclonalantibodypromotesdirectantitumoractivityandprotectivevaccinaleffectinasyngenicmousemelanomamodel AT wonghingc combinationtherapyofanil15superagonistcomplexalt803andatumortargetingmonoclonalantibodypromotesdirectantitumoractivityandprotectivevaccinaleffectinasyngenicmousemelanomamodel |